Total Payments
$2,449
2023 Payments
$807.62
Companies
17
Transactions
22
Medicare Patients
2,151
Medicare Billing
$310,495
Payment Breakdown by Category
Food & Beverage$2,449 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,449 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $323.09 | 3 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $248.37 | 2 | $0 (2023) |
| Novo Nordisk Inc | $236.73 | 2 | $0 (2022) |
| IDORSIA PHARMACEUTICALS US INC | $211.14 | 2 | $0 (2023) |
| Boston Scientific Corporation | $138.43 | 1 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $124.99 | 1 | $0 (2022) |
| Celgene Corporation | $124.06 | 1 | $0 (2021) |
| Dexcom, Inc. | $121.15 | 1 | $0 (2023) |
| UROVANT SCIENCES INC | $120.00 | 1 | $0 (2022) |
| Amarin Pharma Inc. | $119.86 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $807.62 | 7 | Alexion Pharmaceuticals, Inc. ($248.37) |
| 2022 | $1,094 | 10 | Boston Scientific Corporation ($138.43) |
| 2021 | $547.36 | 5 | AstraZeneca Pharmaceuticals LP ($188.57) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $107.10 | General |
| Category: Cardio-renal | ||||||
| 08/16/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $122.37 | General |
| Category: Rare Disease | ||||||
| 07/06/2023 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $119.86 | General |
| Category: Cardiovascular | ||||||
| 06/14/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $126.00 | General |
| 02/14/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $121.15 | General |
| Category: Endocrinology | ||||||
| 01/18/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $105.57 | General |
| Category: INSOMNIA | ||||||
| 01/18/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $105.57 | General |
| Category: INSOMNIA | ||||||
| 11/02/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: Urology | ||||||
| 08/24/2022 | SANOFI PASTEUR INC. | — | Food and Beverage | In-kind items and services | $107.25 | General |
| 07/13/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $98.25 | General |
| 06/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: RESPIRATORY | ||||||
| 05/18/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $120.12 | General |
| Category: Obesity | ||||||
| 04/20/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $134.52 | General |
| 03/24/2022 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $115.61 | General |
| Category: NEUROLOGY | ||||||
| 02/24/2022 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 02/09/2022 | Boston Scientific Corporation | AMS 700 CXR RTE Kit (Device) | Food and Beverage | In-kind items and services | $138.43 | General |
| Category: AMS 700 CXR RTE Kit_URO | ||||||
| 01/19/2022 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $84.90 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/15/2021 | Global Blood Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $118.12 | General |
| 10/21/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $103.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/18/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $116.61 | General |
| Category: Obesity | ||||||
| 07/21/2021 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $124.06 | General |
| 06/23/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $85.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 429 | 676 | $211,143 | $61,003 |
| 2022 | 13 | 603 | 1,011 | $291,870 | $85,146 |
| 2021 | 13 | 531 | 1,012 | $279,040 | $82,994 |
| 2020 | 14 | 588 | 981 | $262,623 | $81,353 |
Total Patients
2,151
Total Services
3,680
Medicare Billing
$310,495
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 144 | 342 | $148,086 | $37,889 | 25.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $15,888 | $6,473 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $10,010 | $4,031 | 40.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 19 | $10,792 | $3,687 | 34.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 24 | 25 | $5,125 | $1,697 | 33.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 23 | $2,530 | $1,644 | 65.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 46 | 50 | $6,600 | $1,641 | 24.9% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 16 | 18 | $5,616 | $1,529 | 27.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 25 | $1,575 | $812.50 | 51.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 23 | 23 | $1,449 | $747.50 | 51.6% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 17 | 50 | $1,450 | $394.50 | 27.2% |
| 90471 | Administration of vaccine | Office | 2023 | 24 | 29 | $1,827 | $348.72 | 19.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 13 | $195.00 | $109.20 | 56.0% |
| 99350 | Established patient home visit, typically 1 hour | Office | 2022 | 142 | 461 | $199,613 | $50,482 | 25.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 66 | 66 | $18,876 | $7,823 | 41.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 21 | 21 | $13,902 | $5,853 | 42.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 21 | 25 | $14,200 | $5,066 | 35.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 63 | 65 | $7,150 | $4,429 | 61.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 56 | 57 | $11,685 | $4,041 | 34.6% |
| 99345 | New patient home visit, typically 75 minutes | Office | 2022 | 23 | 23 | $12,374 | $2,459 | 19.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 65 | 67 | $4,221 | $2,135 | 50.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 23 | 27 | $3,564 | $1,041 | 29.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 26 | 26 | $1,638 | $831.45 | 50.8% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 16 | 78 | $2,262 | $530.38 | 23.4% |
| 90471 | Administration of vaccine | Office | 2022 | 17 | 20 | $1,260 | $232.38 | 18.4% |
About Michael Kingan, CRNP
Michael Kingan, CRNP is a Nurse Practitioner healthcare provider based in Salisbury, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2015. The National Provider Identifier (NPI) number assigned to this provider is 1861871881.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Kingan, CRNP has received a total of $2,449 in payments from pharmaceutical and medical device companies, with $807.62 received in 2023. These payments were reported across 22 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,449).
As a Medicare-enrolled provider, Kingan has provided services to 2,151 Medicare beneficiaries, totaling 3,680 services with total Medicare billing of $310,495. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Salisbury, MD
- Active Since 05/22/2015
- Last Updated 05/22/2015
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1861871881
Products in Payments
- QUVIVIQ (Drug) $211.14
- LOKELMA (Drug) $188.57
- AMS 700 CXR RTE Kit (Device) $138.43
- ULTOMIRIS (Biological) $122.37
- DEXCOM G7 GSS (161) (Medical Supply) $121.15
- Saxenda (Drug) $120.12
- GEMTESA (Drug) $120.00
- Vascepa (Drug) $119.86
- Wegovy (Drug) $116.61
- SUNOSI (Drug) $115.61
- Kerendia (Drug) $107.10
- Omnia (Device) $84.90
- OFEV (Drug) $50.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Salisbury
Lisa Whitley, Pmhs, PMHS
Nurse Practitioner — Payments: $18,600
Nurse Practitioner $18,600
Tanya Clifford, Crnp, CRNP
Nurse Practitioner — Payments: $8,099
Nurse Practitioner $8,099
Mrs. Erin Perdue, Crnp, CRNP
Nurse Practitioner — Payments: $6,659
Nurse Practitioner $6,659
Sylvia Dickerson, F.n.p, F.N.P
Nurse Practitioner — Payments: $5,161
Nurse Practitioner $5,161
Tammy Burke, Np, NP
Nurse Practitioner — Payments: $4,393
Nurse Practitioner $4,393
Mrs. Kimberly Rogers, N.p, N.P
Nurse Practitioner — Payments: $3,705
Nurse Practitioner $3,705